RIPOR2 promotes multinucleation of melanoma cells downstream of the RAS/ERK oncogenic pathway
Axelle Wilmerding, Aurélie Richard, Nicolas Macagno, Estelle Hirsinger, Tarek Gharsalli, Léa Bellenger, Naïra Naouar, Caroline Gaudy‐Marqueste, S. Mallet, N. Dégardin, Lauranne Bouteille, Nathalie Caruso, Delphine Duprez, Yacine Graba, Souhila Medjkane, , Marie-Claire Delfini
This study identifies RIPOR2 as a downstream target of the RAS/ERK pathway that promotes multinucleation in melanoma cells, contributing to aneuploidy and tumor progression.
iScience · Apr 15, 2026Peer-reviewedCancer Biology